286 related articles for article (PubMed ID: 22033267)
41. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains.
Kolb M; Bonniaud P; Galt T; Sime PJ; Kelly MM; Margetts PJ; Gauldie J
Am J Respir Cell Mol Biol; 2002 Aug; 27(2):141-50. PubMed ID: 12151305
[TBL] [Abstract][Full Text] [Related]
42. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
[TBL] [Abstract][Full Text] [Related]
43. Regulation of transforming growth factor-beta1 (TGF-β1)-induced pro-fibrotic activities by circadian clock gene BMAL1.
Dong C; Gongora R; Sosulski ML; Luo F; Sanchez CG
Respir Res; 2016 Jan; 17():4. PubMed ID: 26753996
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA H19 deficiency ameliorates bleomycin-induced pulmonary inflammation and fibrosis.
Wan X; Tian X; Du J; Lu Y; Xiao Y
Respir Res; 2020 Nov; 21(1):290. PubMed ID: 33138822
[TBL] [Abstract][Full Text] [Related]
45. Effect of intramuscular injection of hepatocyte growth factor plasmid DNA with electroporation on bleomycin-induced lung fibrosis in rats.
Long X; Xiong SD; Xiong WN; Xu YJ
Chin Med J (Engl); 2007 Aug; 120(16):1432-7. PubMed ID: 17825173
[TBL] [Abstract][Full Text] [Related]
46. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.
Nakamura H; Siddiqui SS; Shen X; Malik AB; Pulido JS; Kumar NM; Yue BY
Mol Vis; 2004 Oct; 10():703-11. PubMed ID: 15475878
[TBL] [Abstract][Full Text] [Related]
47. Transforming Growth Factor-β1 Regulates Peroxisomal Genes/Proteins via Smad Signaling in Idiopathic Pulmonary Fibrosis Fibroblasts and Transgenic Mouse Models.
Oruqaj G; Karnati S; Kotarkonda LK; Boateng E; Bartkuhn M; Zhang W; Ruppert C; Günther A; Bartholin L; Shi W; Baumgart-Vogt E
Am J Pathol; 2023 Mar; 193(3):259-274. PubMed ID: 36521562
[TBL] [Abstract][Full Text] [Related]
48. Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression.
Cutroneo KR; White SL; Phan SH; Ehrlich HP
J Cell Physiol; 2007 Jun; 211(3):585-9. PubMed ID: 17387717
[TBL] [Abstract][Full Text] [Related]
49. Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-β1 and plasminogen activator inhibitor 1.
Li XX; Li N; Ban CJ; Zhu M; Xiao B; Dai HP
Chin Med J (Engl); 2011 Jul; 124(13):1923-7. PubMed ID: 22088447
[TBL] [Abstract][Full Text] [Related]
50. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.
Liang H; Gu Y; Li T; Zhang Y; Huangfu L; Hu M; Zhao D; Chen Y; Liu S; Dong Y; Li X; Lu Y; Yang B; Shan H
Cell Death Dis; 2014 May; 5(5):e1238. PubMed ID: 24853416
[TBL] [Abstract][Full Text] [Related]
51. Effects of RNA interference-induced Smad3 gene silencing on pulmonary fibrosis caused by paraquat in mice.
Dong XS; Hu XB; Liu W; Sun YQ; Liu Z
Exp Biol Med (Maywood); 2012 May; 237(5):548-55. PubMed ID: 22581813
[TBL] [Abstract][Full Text] [Related]
52. Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma.
Nakamura-Wakatsuki T; Oyama N; Yamamoto T
Exp Dermatol; 2012 Mar; 21(3):189-94. PubMed ID: 22188586
[TBL] [Abstract][Full Text] [Related]
53. Modulation of CD11c+ lung dendritic cells in respect to TGF-β in experimental pulmonary fibrosis.
Chakraborty K; Chatterjee S; Bhattacharyya A
Cell Biol Int; 2017 Sep; 41(9):991-1000. PubMed ID: 28557137
[TBL] [Abstract][Full Text] [Related]
54. [Study on treatment effect and mechanism of Hirsutella sinensis mycelium in idiopathic pulmonary fibrosis in rats].
Shou QY; Fu HY; Zhang LZ; Cai YQ; Chen FM; Chen ML
Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3618-23. PubMed ID: 23477151
[TBL] [Abstract][Full Text] [Related]
55. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
[TBL] [Abstract][Full Text] [Related]
56. Bach1 siRNA attenuates bleomycin-induced pulmonary fibrosis by modulating oxidative stress in mice.
Liu Y; Zheng Y
Int J Mol Med; 2017 Jan; 39(1):91-100. PubMed ID: 27959382
[TBL] [Abstract][Full Text] [Related]
57. Antifibrotic role of αB-crystallin inhibition in pleural and subpleural fibrosis.
Bellaye PS; Burgy O; Colas J; Fabre A; Marchal-Somme J; Crestani B; Kolb M; Camus P; Garrido C; Bonniaud P
Am J Respir Cell Mol Biol; 2015 Feb; 52(2):244-52. PubMed ID: 25032514
[TBL] [Abstract][Full Text] [Related]
58. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
59. Antifibrosis effects of total glucosides of Danggui-Buxue-Tang in a rat model of bleomycin-induced pulmonary fibrosis.
Gao J; Huang Y; Li P; Xu D; Li J; Liu Y; Huang Z; Wu Q; Shao X
J Ethnopharmacol; 2011 Jun; 136(1):21-6. PubMed ID: 21421041
[TBL] [Abstract][Full Text] [Related]
60. Effects of Th2 pulmonary inflammation in mice with bleomycin-induced pulmonary fibrosis.
Hirata H; Arima M; Fukushima Y; Ishii Y; Tokuhisa T; Fukuda T
Respirology; 2008 Nov; 13(6):788-98. PubMed ID: 18811877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
